Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population

被引:18
作者
Tinahones, FJ [1 ]
Gómez-Zumaquero, JM [1 ]
Rojo-Martínez, G [1 ]
Cardona, F [1 ]
de Antonio, IE [1 ]
de Adana, MSR [1 ]
Soriguer, FJ [1 ]
机构
[1] Carlos Haya Reg Hosp, Serv Endocrinol, Metab Unit, Malaga, Spain
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2002年 / 51卷 / 04期
关键词
D O I
10.1053/meta.2002.31320
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoantibodies against epitopes of oxidized low-density lipoprotein (LDL), initially shown in human sera, were later related with the atherosclerotic process, although recent studies have questioned this association. Moreover, their association with total cholesterol and plasma LDL, or with the other lipoproteins, is not clear. We studied the relation between the levels of autoantibodies to oxidized LDL and lipoproteins in a population of 400 subjects from the lower Guadalhorce area in Malaga, Spain. Anti-oxidized LDL antibodies were measured by enzyme-linked immunosorbent assay (ELISA), and total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and lipoprotein(a) [Lp(a)] were measured with commercial kits. Subjects who were positive for anti-oxidized LDL antibodies had significantly lower levels of total cholesterol (P <.01) and LDL cholesterol (P <.01). There was a negative correlation between titers of anti-oxidized LDL antibodies and levels of total cholesterol (P =.007) and LDL cholesterol (P =.024). This inverse relation between the levels of anti-oxidized LDL antibodies and the levels of total cholesterol and LDL cholesterol in a large population study, together with the discordances already published, suggests that the relation between anti-oxidized LDL antibodies, arteriosclerosis, and lipids is more complex than initially thought. Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:429 / 431
页数:3
相关论文
共 21 条
  • [1] Amengual O, 1997, BRIT J RHEUMATOL, V36, P964
  • [2] AUTOANTIBODIES AGAINST OXIDATIVELY MODIFIED LOW-DENSITY LIPOPROTEINS IN NIDDM
    BELLOMO, G
    MAGGI, E
    POLI, M
    AGOSTA, FG
    BOLLATI, P
    FINARDI, G
    [J]. DIABETES, 1995, 44 (01) : 60 - 66
  • [3] ANTI-OXIDIZED LDL ANTIBODIES AND ANTIPHOSPHOLIPID ANTIBODIES IN HEALTHY-SUBJECTS - RELATIONSHIP WITH LIPOPROTEIN-RELATED AND OXIDATION-RELATED ANALYTES
    CRAIG, WY
    POULIN, SE
    NEVEUX, LM
    PALOMAKI, GE
    DOSTALJOHNSON, DA
    LEDUE, TB
    RITCHIE, RF
    [J]. JOURNAL OF AUTOIMMUNITY, 1995, 8 (05) : 713 - 726
  • [4] Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications
    Festa, A
    Kopp, HP
    Schernthaner, G
    Menzel, EJ
    [J]. DIABETOLOGIA, 1998, 41 (03) : 350 - 356
  • [5] Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL
    Heikkinen, AM
    Niskanen, L
    Ylä-Herttuala, S
    Luoma, J
    Tuppurainen, MT
    Komulainen, M
    Saarikoski, S
    [J]. MATURITAS, 1998, 29 (02) : 155 - 161
  • [6] Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease
    Hoogerbrugge, N
    Zillikens, MC
    Jansen, H
    Meeter, K
    Deckers, JW
    Birkenhäger, JC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (06): : 675 - 680
  • [7] Hoogerbrugge N, 1998, J INTERN MED, V243, P355
  • [8] Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia
    Hulthe, J
    Wikstrand, J
    Lidell, A
    Wendelhag, I
    Hansson, GK
    Wiklund, O
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (08) : 1203 - 1211
  • [9] Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease
    Korpinen, E
    Groop, PH
    Akerblom, HK
    Vaarala, O
    [J]. DIABETES CARE, 1997, 20 (07) : 1168 - 1171
  • [10] Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus
    Lopes-Virella, MF
    Virella, G
    Orchard, TJ
    Koskinen, S
    Evans, RW
    Becker, DJ
    Forrest, KYZ
    [J]. CLINICAL IMMUNOLOGY, 1999, 90 (02) : 165 - 172